» Articles » PMID: 25351557

Analysis of Thyroid Malignant Pathologic Findings Identified During 3 Rounds of Screening (1997-2008) of a Cohort of Children and Adolescents from Belarus Exposed to Radioiodines After the Chernobyl Accident

Abstract

Background: Recent studies of children and adolescents who were exposed to radioactive iodine-131 (I-131) after the 1986 Chernobyl nuclear accident in Ukraine exhibited a significant dose-related increase in the risk of thyroid cancer, but the association of radiation doses with tumor histologic and morphologic features is not clear.

Methods: A cohort of 11,664 individuals in Belarus who were aged ≤18 years at the time of the accident underwent 3 cycles of thyroid screening during 1997 to 2008. I-131 thyroid doses were estimated from individual thyroid activity measurements taken within 2 months after the accident and from dosimetric questionnaire data. Demographic, clinical, and tumor pathologic characteristics of the patients with thyroid cancer were analyzed using 1-way analysis of variance, chi-square tests or Fisher exact tests, and logistic regression.

Results: In total, 158 thyroid cancers were identified as a result of screening. The majority of patients had T1a and T1b tumors (93.7%), with many positive regional lymph nodes (N1; 60.6%) but few distant metastases (M1; <1%). Higher I-131 doses were associated with higher frequency of solid and diffuse sclerosing variants of thyroid cancer (P < .01) and histologic features of cancer aggressiveness, such as lymphatic vessel invasion, intrathyroidal infiltration, and multifocality (all P < .03). Latency was not correlated with radiation dose. Fifty-two patients with self-reported thyroid cancers which were diagnosed before 1997 were younger at the time of the accident and had a higher percentage of solid variant cancers compared with patients who had screening-detected thyroid cancers (all P < .0001).

Conclusions: I-131 thyroid radiation doses were associated with a significantly greater frequency of solid and diffuse sclerosing variants of thyroid cancer and various features of tumor aggressiveness.

Citing Articles

International patterns and trends of childhood and adolescent cancer, 1978-2012.

Zhao Y, Sun P, Xiao J, Jin L, Ma N, Li Z J Natl Cancer Cent. 2024; 2(2):78-89.

PMID: 39034956 PMC: 11256536. DOI: 10.1016/j.jncc.2022.02.001.


A Historical Survey of Key Epidemiological Studies of Ionizing Radiation Exposure.

Little M, Bazyka D, Berrington de Gonzalez A, Brenner A, Chumak V, Cullings H Radiat Res. 2024; 202(2):432-487.

PMID: 39021204 PMC: 11316622. DOI: 10.1667/RADE-24-00021.1.


Radiation Dose Does Not Affect the Predictive Value of Thyroid Biopsy for Diagnosing Papillary Thyroid Cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.

McConnell R, Kamysh O, OKane P, Greenebaum E, Rozhko A, Yauseyenka V Acta Cytol. 2024; 68(1):34-44.

PMID: 38246154 PMC: 10987278. DOI: 10.1159/000536387.


Incidentally Detected Metachronous Malignancy in Patients of Papillary Carcinoma of Thyroid Posthigh-Dose Radioiodine Therapy.

Mishra A, Singh V, Khandelwal Y, Smitha A, Kavali D, Barai S Indian J Nucl Med. 2023; 38(3):264-269.

PMID: 38046960 PMC: 10693376. DOI: 10.4103/ijnm.ijnm_188_22.


Epidemiology of Thyroid Cancer.

Kitahara C, Schneider A Cancer Epidemiol Biomarkers Prev. 2022; 31(7):1284-1297.

PMID: 35775227 PMC: 9473679. DOI: 10.1158/1055-9965.EPI-21-1440.


References
1.
Grigsby P, Michalski J, Doherty G . Childhood and adolescent thyroid carcinoma. Cancer. 2002; 95(4):724-9. DOI: 10.1002/cncr.10725. View

2.
Stezhko V, Buglova E, Danilova L, Drozd V, Krysenko N, Lesnikova N . A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methods. Radiat Res. 2004; 161(4):481-92. DOI: 10.1667/3148. View

3.
Williams E, Abrosimov A, Bogdanova T, Demidchik E, Ito M, LiVolsi V . Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer. 2004; 90(11):2219-24. PMC: 2409486. DOI: 10.1038/sj.bjc.6601860. View

4.
Holm L, Wiklund K, Lundell G, BERGMAN N, Bjelkengren G, Ericsson U . Cancer risk in population examined with diagnostic doses of 131I. J Natl Cancer Inst. 1989; 81(4):302-6. DOI: 10.1093/jnci/81.4.302. View

5.
Holm L, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G . Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst. 1991; 83(15):1072-7. DOI: 10.1093/jnci/83.15.1072. View